<DOC>
	<DOCNO>NCT00553124</DOCNO>
	<brief_summary>RATIONALE : Studying different factor effect patient newly diagnose bladder cancer may help doctor learn disease , improve ability plan cancer treatment , help patient live comfortably . PURPOSE : This clinical trial study different factor affect patient newly diagnose bladder cancer .</brief_summary>
	<brief_title>Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To assess effect lifestyle factor ( e.g. , smoking , dietary habit , fluid intake , environmental exposure ) recurrence progression bladder cancer . - To assess impact selenium and/or vitamin E progression recurrence bladder cancer . - To study health-related quality life association recurrence progression bladder cancer . - To establish bladder cancer tissue bank comprise blood , urine , bladder tissue . - To study predictive effect molecular marker recurrence progression bladder cancer . OUTLINE : This multicenter study . The study base cohort patient newly detect bladder cancer 16 urological centre within West Midlands , commence late 2005 period 5 year . This research project consist 5 individual study : CRUK-BCPP-2005-01-COHORT , CRUK-BCPP-2005-01-MARKERS , CRUK-BCPP-2005-01-QOL , CRUK-BCPP-2005-01-TISSUE-BANK , CRUK-BCPP-2005-01-TREATMENT . Patients may participate individual study . Peer Reviewed Funded Endorsed Cancer Research UK .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Bladder lesion cystoscopic characteristic compatible urothelial cancer transitional cell carcinoma meet 1 follow criterion : Nonmuscleinvasive tumor Muscleinvasive tumor Solitary G1 pTa tumor No previous diagnosis cancer urethra , bladder , ureter , renal pelvis within 10 year prior current diagnosis PATIENT CHARACTERISTICS : Fit cystoscopy surgical biopsy/resection No HIV infection No condition , opinion local investigator , might interfere safety patient evaluation study objective PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>stage 0 bladder cancer</keyword>
	<keyword>stage I bladder cancer</keyword>
	<keyword>stage II bladder cancer</keyword>
	<keyword>transitional cell carcinoma bladder</keyword>
</DOC>